Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.5M |
 |
Gilead SciencesGILD |
-$4.04B |
 |
AmgenAMGN |
-$189M |
 |
Editas MedicineEDIT |
-$7M |
 |
Crispr TherapeuticsCRSP |
-$177M |
Are Ensysce Biosciences Insiders Buying or Selling?
Ensysce Biosciences (ENSC) has had 1 insider transaction in the past 90 days, all buys — insider buying is generally read as a bullish signal. The most recent was BOB GOWER, who bought 400,000 shares at $0.50 on August 7, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the ENSC AI Score. For government officials trading this stock, see ENSC congressional trading.
Who’s Trading Ensysce Biosciences Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| BOB GOWER | Bought $440,000 | 2 | Aug 7, 2026 |
Recent Ensysce Biosciences Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| BOB GOWER | Aug 7, 2026 | Buy | 400,000 | $0.5 | $200,000 |
| BOB GOWER | Apr 23, 2026 | Buy | 508,614 | $0.48 | $250,000 |
Frequently Asked Questions: Ensysce Biosciences Insider Trading
In the past 90 days, Ensysce Biosciences insiders have made 1 buy and 0 sells. The net buying may indicate insider confidence in the company’s outlook.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
GOWER BOB G has bought the most ENSC stock in the last 2 years, with a total value of $440,000.
According to our estimates, the total value of insider transactions for Ensysce Biosciences in the last 2 years is positive, amounting to $440,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
